Prosecution Insights
Last updated: October 26, 2026

Bruck Kifle, USPTO Patent Examiner

Listed by the USPTO as KIFLE, BRUCK

Tech Center 1600 • Art Units: 1622 1624 1626 1629

This examiner grants 79% of resolved cases

Analysis

Bruck Kifle has handled 1742 resolved cases in Art Unit 1622. The examiner has an allowance rate of 79.3 percent. The median time to reach an allowance is 670 days. Gilead Sciences Inc., Omeros Corporation, and Compass Pathfinder Limited are the most frequent companies. This high volume of 1742 resolved cases reflects extensive experience in Tech Center 1600.

The interview lift is 15.8 percent, indicating that interviews are a productive strategy for practitioners. BakerHostetler, ARENTFOX SCHIFF LLP, and Brannon Sowers & Cracraft PC are the top firms. The 79.3 percent allowance rate suggests a favorable environment for patent grants. A median of 670 days to allowance is an exceptionally efficient duration. The 15.8 percent lift provides a clear statistical reason to consider examiner interviews as part of the prosecution strategy for these cases.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

79.3%
Allow Rate
+19.3% vs TC avg
1,788
Total Applications
+15.8%
Interview Lift
670
Avg Prosecution Days
Based on 1742 resolved cases, 2023–2026

Rejection Statute Breakdown

5.9%
§101 Eligibility
12.2%
§102 Novelty
12.7%
§103 Obviousness
53.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18556250 PI3K INHIBITORS, NANOFORMULATIONS, AND USES THEREOF Non-Final OA THE REGENTS OF THE UNIVERSITY OF MICHIGAN
19022367 REVERSIBLE FIXING REAGENTS AND METHODS OF USE THEREOF Non-Final OA 10x Genomics, Inc.
18599116 COMPOUNDS AND THE USES AND PHARMACEUTICAL COMPOSITIONS THEREOF Final Rejection Lemon Inc.
18715470 FUNGICIDAL COMPOSITIONS Non-Final OA SYNGENTA CROP PROTECTION AG
18757200 IRE1 SMALL MOLECULE INHIBITORS Non-Final OA Cornell University
18688995 PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB Non-Final OA MIRATI THERAPEUTICS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Bruck Kifle's allowance rate?

79.3% of resolved applications examined by Bruck Kifle were allowed (1,742 resolved cases), compared with 60.6% across Art Unit 1622 over the last five years.

Does an interview help with examiner Bruck Kifle?

This examiner's interview lift is +15.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Bruck Kifle take to allow a patent?

Applications allowed by Bruck Kifle took 670 days on average from filing to allowance.

Which art unit does examiner Bruck Kifle work in?

Bruck Kifle examines applications in Art Unit 1622 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month